Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: A randomized controlled trial

Journal of Perinatology

Volumn 25, Issue 11, 2005, Pages 703-708

  Reininger, Ann ^a   Khalak, Rubia ^b   Kendig, James W ^c   Ryan, Rita M ^d   Stevens, Timothy P ^a   Reubens, Linda ^a   D'Angio, Carl T ^a,e  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b St Peter's Hospital Albany   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; BERACTANT; OXYGEN;

ARTICLE; ARTIFICIAL VENTILATION; BREATHING APPARATUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG USE; EXTUBATION; GESTATIONAL AGE; HUMAN; INTUBATION; LENGTH OF STAY; LUNG DYSPLASIA; LUNG MINUTE VOLUME; MAJOR CLINICAL STUDY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

BIOLOGICAL PRODUCTS; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; INFANT, NEWBORN; MALE; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TIME FACTORS;

EID: 27844457211     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211381     Document Type: Article

References (24)

1. Rodriguez RJ. Management of respiratory distress syndrome: An update. Respir Care 2003;48:279-87.
2. Schimmel MS, Hammerman C. Early nasal continuous positive airway pressure with or without prophylactic surfactant therapy in the premature infant with respiratory distress syndrome. Pediatr Radiol 2000;30:713-4.
3. Egberts J, Brand R, Walti H, Bevilacqua G, Breart G, Gardini F. Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf. Pediatrics 1997;100:E4 (http://www.pediatrics.org/cgi/content/full/100/1/e4).
4. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959;97:517-23.
5. Verder H, Robertson B, Greisen G et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med 1994;331:1051-5.
6. Verder H, Albertsen P, Ebbesen F, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics 1999;103:E24 (http://www.pediatrics.org/cgi/content/full/103/2/e24).
7. Kendig JW, Notter RH, Cox C et al. Surfactant replacement therapy at birth: Final analysis of a clinical trial and comparisons with similar trials. Pediatrics 1988;82:756-62.
8. Victorin LH, Deverajan LV, Curstedt T, Robertson B. Surfactant replacement in spontaneously breathing babies with hyaline membrane disease - a pilot study. Biol Neonate 1990;58:121-6.
9. Long W, Corbet A, Cotton R, et al. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. N Engl J Med 1991;325:1696-703.
10. Alba J, Agarwal R, Hegyi T, Hiatt IM. Efficacy of surfactant therapy in infants managed with CPAP. Pediatr Pulm 1995;20:172-6.
11. Soll RF. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2003;1.
12. Kattwinkel J, Bloom BT, Delmore P, et al. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Pediatrics 1993;92:90-8.
13. Dunn MS, Shennan AT, Zayack D, Possmayer F. Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: A randomized controlled trial of prophylaxis versus treatment. Pediatrics 1991;87:377-86.
14. Bevilacqua G, Halliday H, Parmigiani S, Robertson B. Randomized multicentre trial of treatment with porcine natural surfactant for moderately severe neonatal respiratory distress syndrome. The Collaborative European Multicentre Study Group. J Perinat Med 1993;21:329-40.
15. Bevilacqua G, Parmigiani S, Robertson B. Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: A multicentre prospective randomized trial. J Perinat Med 1996;24:609-20.
16. Jobe AH. Pulmonary surfactant therapy. N Engl J Med 1993;328:861-8.
17. Lang MJ, Hall RT, Reddy NS, Kurth CG, Merritt TA. A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants. J Pediatr 1990;116:295-300.
18. Mandy GT, Moise AA, Smith EO, Hansen TN. Endotracheal continuous positive airway pressure after rescue surfactant therapy. J Perinatol 1998;18:444-8.
19. Haberman B, Shankaran S, Stevenson DK, et al. Does surfactant (S) and immediate extubation to nasal continuous positive airway pressure (CPAP) reduce use of mechanical ventilation? Pediatr Res 2002;51:349A.
20. Soll RF, Conner JM, Howard D. Early surfactant replacement in spontaneously breathing premature infants with RDS. Pediatr Res 2003;53:L312.
21. Escobedo MB, Gunkel JH, Kennedy KA, et al. Early surfactant for neonates with mild to moderate respiratory distress syndrome: A multicenter, randomized trial. J Pediatr 2004;144:804-8.
22. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-9.
23. D'Angio CT, Khalak R, Stevens TP, et al. Intratracheal surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with RDS requiring nasal CPAP decreases the likelihood of later mechanical ventilation: A randomized controlled trial. Pediatr Res 2003;53:367A.
24. Stevens TP, Blennow M, Soll RF. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database of Systematic Reviews 2005;1.